11.30.22 -- Unexpected Results: What I Learned During 12 Site Audits In Africa

Except for South Africa, sub-Saharan African countries are still largely underrepresented in the global clinical study map. Hesitation to conduct clinical studies in Africa may be partly a result of assumed poor infrastructure, missing regulations, and inexperienced researchers. But is it truly so? Or is our thinking stuck somewhere in the past?

This webinar examines the advantages of conducting trials in this fast-growing region and delves into other issues sponsors should consider when choosing sites for upcoming trials.

Due to the continuous growth in drug development costs, there has never been a greater need for new and innovative ways to support the clinical trial supply chain. Explore key trends that are pushing the innovation envelope.

Find out how long-term follow-up (LTFU) studies for gene therapies present unique challenges and highlight important considerations for different kinds of sponsors, including biotech and emerging biopharma.

Learn about the advantages of home visits for clinical trials and what research nurses do to make this possible.

In today’s unpredictable clinical landscape, read about complex challenges and innovative strategies to safely deliver lifesaving advanced treatments to patients.

This Q&A discusses the benefits of good study design for sponsors and sites, the downstream effects of standardized study designs, and the tips for designing it on your own.

Discover how the increase in demand for early detection and diagnostic modalities promotes a proactive versus reactive approach to medicine — something that can drive improved patient outcomes.

Explore how scenario planning enables you to find the best strategy while balancing risks and costs and gives you the ability to arm your internal stakeholders with impact assessment data based on plausible scenarios.

In this webinar, attendees will learn how experts apply imaging science and operational expertise to identify and manage the inherent risks when capturing complete and high-quality central review data of study endpoints.

Experts speak on supply capabilities within interactive response technology (IRT) and how flexibility is important to functionality, who to involve, and which questions to ask in optimizing IRT for clinical supply.

Solara enables exponentially larger exploration of the study design space. This patent-pending, collaborative, decision-support platform reveals innovative opportunities to shorten trial duration, increase power, and reduce cost.

Our work spans all aspects of clinical trials and drug development, encompassing more than 190 rare disease studies across multiple indications in the past five years with seven successful drug approvals and three Breakthrough designations.

At this time of year, I receive numerous emails from companies outlining predictions for the coming year from some of their executives. Here are a few I'd like to share, based on emails I received from Mobiquity, Veeva, 4G Clinical, Cognizant, and others who were kind enough to share their insights.

Clinical sites and sponsors have had to quickly implement solutions, and biopharma companies are heeding the call to innovate, be agile, reduce waste, and, most of all, achieve patient centricity.

Gain insight into how a combination of consulting and technology enabled a CRO to reduce the time and cost of a clinical study so that the team could take quick action to reduce risk and improve patient safety.

In this webinar, experts discuss how enriching oncology clinical trials with RWD generates deeper insights and improves operational efficiency to achieve better patient outcomes.

During this webinar, speakers will debunk common myths associated with novel approaches to data collection using technology and highlight strategies to improve the patient experience, without compromising quality, speed, or cost.

Read this webinar presentation as panelists share lessons learned and recommendations for designing protocols that enable flexibility in your virtual trials’ conduct.

Watch this video to learn what steps the industry can take to remove the technology burden on clinical research sites.

Many DCT stakeholders have attempted to release terminology guides as relates to their own dealings; however, there had never been a wide range of universalized DCT terms until now.